Innovid Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Portfolio Pulse from Benzinga Insights
Innovid (NYSE:CTV) has received mixed analyst ratings over the past three months, with a majority being bullish. Analysts have set a 12-month price target range of $2.50 to $3.00, with an average target of $2.9, reflecting a slight increase from previous estimates. Despite positive revenue growth, the company faces challenges in profitability and asset utilization.
August 06, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Innovid has received mixed analyst ratings, with a majority being bullish. The average 12-month price target has increased to $2.9. Despite strong revenue growth, the company faces challenges in profitability and asset utilization.
The majority of analysts are bullish on Innovid, and the average price target has increased, indicating positive sentiment. However, the company's profitability and asset utilization challenges may temper short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100